Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: The ETRA study. Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)26-27
Number of pages2
JournalInternational Journal of Advances in Rheumatology
Volume9
Issue number1
StatePublished - 2011

ASJC Scopus subject areas

  • Rheumatology

Cite this